Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 958 of 5804
-
New device aims to stop a 'Never Event' that still happens in childbirth
Prevention Not yet recruitingAccidentally retained surgical items or swabs are well-recognised errors that result in adverse consequences for patients. This error is one of the commonest "Never Events" - patient safety incidents that are considered preventable. Although uncommon, these incidents can have dev…
Sponsor: The Royal Wolverhampton Hospitals NHS Trust • Aim: Prevention
Last updated Jun 27, 2026 12:05 UTC
-
Veterans with spinal injury may have hidden nerve pathways, new study hopes to find
Knowledge-focused Not yet recruitingChronic spinal cord injury (SCI) is a debilitating disorder in Veterans and the broader U.S. population that does not have a cure. Veterans with severe SCI demonstrate permanent loss of sensory and motor function below their injury resulting in decreased quality of life and indep…
Phase: NA • Sponsor: VA Office of Research and Development • Aim: Knowledge-focused
Last updated Jul 19, 2026 00:00 UTC
-
Veterans' chronic back pain may be eased by natural brain molecules in new trial
Symptom relief Not yet recruitingChronic pain symptoms are very common among U.S. Military Veterans and have a profound negative impact on mental health symptoms and quality of life, in addition to increasing risk for suicidal ideation and suicidal behaviors. There are currently extremely few safe and effective …
Phase: PHASE2 • Sponsor: VA Office of Research and Development • Aim: Symptom relief
Last updated Jun 27, 2026 13:03 UTC
-
Could ketamine replace morphine for kids in pain?
Symptom relief Not yet recruitingPain is common in children presenting to the emergency department but is frequently undertreated, leading to both short- and long-term consequences. Morphine is the standard treatment for children with moderate to severe acute pain, but its use is associated with serious side eff…
Phase: PHASE3 • Sponsor: Columbia University • Aim: Symptom relief
Last updated Jun 27, 2026 13:04 UTC
-
New scan and urine test could revolutionize bladder cancer staging
Diagnosis Not yet recruitingThe study will be a prospective two arms diagnostic phase II single-center trial. Patients referred for diagnosis and treatment with diagnosis of bladder cancer, age \> 18 years, ECOG performance status \< 2, ability to undergo an imaging study procedure will be considered for i…
Phase: PHASE2 • Sponsor: Chiti Arturo • Aim: Diagnosis
Last updated Jun 27, 2026 08:01 UTC
-
AI-Powered lifestyle app aims to ease Parkinson's symptoms
Symptom relief Not yet recruitingLifestyle interventions can alleviate Parkinson's Disease (PD) symptoms and delay disease progression. The novelty of this project lies in the development of an innovative smart platform that utilizes artificial intelligence (AI) and predictive models to offer a groundbreaking so…
Sponsor: University Ramon Llull • Aim: Symptom relief
Last updated Jun 27, 2026 08:00 UTC
-
Could a common heart drug treat kaposi sarcoma?
Disease control Not yet recruitingA clinical study of propranolol for the treatment of Kaposi Sarcoma in children and adults. This study will be an open-label single armed treatment trial that will test the effectiveness and the safety of treating Kaposi Sarcoma with propranolol.
Phase: PHASE2 • Sponsor: AIDS Malignancy Consortium • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC
-
Simple Pre-Surgery trick may shield kidneys from damage
Disease control Not yet recruitingJuxta-renal abdominal aortic aneurysms (AAA) are challenging to treat with standard endovascular techniques (EVAR) due to their proximity to the renal arteries. Open surgical repair continues to be used in patients unsuitable for EVAR but carries a high risk of acute kidney injur…
Phase: NA • Sponsor: University Hospital, Rouen • Aim: Disease control
Last updated Jun 27, 2026 13:04 UTC
-
Brain stent trial aims to ease pressure headaches and save sight
Disease control Not yet recruitingThe objective of this clinical investigation is to evaluate and demonstrate the clinical benefit, performance, and safety of the SILANCE Stent, which is specifically designed for the treatment of patients with symptomatic sinus stenoses associated with IIH.
Phase: NA • Sponsor: Acandis GmbH • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC
-
Potassium binder may help heart failure patients stay on lifesaving drugs
Disease control Not yet recruitingA multicenter, randomized, controlled study in Sweden (n=110). This study consists of 2 phases: 1) open-label run-in within approximately 2 months, and 2) randomized, double-blinded and placebo-controlled treatment for 6 months. The open-label phase, in turn, consists of three p…
Phase: PHASE2 • Sponsor: Sahlgrenska University Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC
-
Blood test could predict vasculitis relapse, study hopes
Knowledge-focused Not yet recruitingANCA-associated vasculitis is a serious autoimmune disease. The standard treatment is rituximab (RTX), which depletes B-cells to control inflammation. However, identifying patients at high risk of relapse remains a challenge, often leading to unnecessarily long treatments and sid…
Sponsor: Nantes University Hospital • Aim: Knowledge-focused
Last updated Jul 09, 2026 00:00 UTC
-
New CAR T-Cell therapy targets Hard-to-Treat myeloma
Disease control Not yet recruitingThe goal of this study is to evaluate the safety of a new type of CAR T-cell, UF-KURE-BCMA, for the treatment of patients with advanced multiple myeloma that has not responded to other therapies. The main question is whether the use of these new CAR T-cells is safe for patients w…
Phase: PHASE1 • Sponsor: Kure Cells, INC • Aim: Disease control
Last updated Jun 27, 2026 12:38 UTC
-
Zapping prostate tumors with extra precision: new trial aims for fewer side effects
Disease control Not yet recruitingThe goal of this clinical trial is to determine the safety of stereotactic body radiation therapy (SBRT) microboost technique in patients with low to intermediate risk prostate cancer. The main question it aims to answer is: Is microboost SBRT with whole gland de-escalation both …
Phase: PHASE2 • Sponsor: Georgetown University • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
Could a radiofrequency device help fight advanced breast cancer?
Disease control Not yet recruitingThe goal of this clinical trial is to learn if adding the TheraBionic P1 device to standard of care third line treatment for adult women with metastatic triple negative breast cancer (mTNBC) who have failed, not tolerated, or progressed on standard first- and second-line treatmen…
Phase: NA • Sponsor: Barbara Ann Karmanos Cancer Institute • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
Gene hunt: could sequencing families unlock the roots of mysterious mental illness?
Knowledge-focused Not yet recruitingAccording to the World Health Organization, one in eight people worldwide has a mental disorder, defined as a significant impairment in thinking, emotional regulation, or behavior. These disorders are classified according to the DSM-5. These psychiatric disorders may be atypical …
Sponsor: Centre Hospitalier Universitaire Dijon • Aim: Knowledge-focused
Last updated Jul 09, 2026 00:00 UTC
-
Smartphone app aims to curb HIV in emergency rooms
Prevention Not yet recruitingThe goal of this clinical trial is to pilot test a psychosocial-behavioral mobile health (mHealth) human immunodeficiency virus (HIV) prevention intervention in people who use drugs presenting to the emergency department (ED). The main question the study aims to answer is: is the…
Phase: NA • Sponsor: Brigham and Women's Hospital • Aim: Prevention
Last updated Jul 11, 2026 00:00 UTC
-
Scientists probe tumor environment to predict drug resistance in stomach cancer
Knowledge-focused Not yet recruitingSurgical resection remains the only curative option for resectable gastric cancer, but perioperative FLOT chemotherapy is associated with substantial rates of chemoresistance and recurrence, largely driven by marked tumor heterogeneity. Recent data from the MATTERHORN phase III t…
Sponsor: Azienda Ospedaliera Specializzata in Gastroenterologia Saverio de Bellis • Aim: Knowledge-focused
Last updated Jul 11, 2026 00:00 UTC
-
Could fewer injections keep kids' eye inflammation in check?
Disease control Not yet recruitingThe goal of this clinical trial is to learn whether children and young adults with well-controlled juvenile idiopathic arthritis (JIA)-associated uveitis or chronic anterior uveitis can safely take adalimumab (or biosimilar) injections less often while maintaining control of thei…
Phase: PHASE4 • Sponsor: Nisha Acharya • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC
-
Could a Once-Daily inhaler replace four daily doses for COPD attacks?
Disease control Not yet recruitingThe primary aim is to determine whether nebulized Formoterol twice daily plus Revefenacin once daily is non-inferior to standard-of-care nebulized Albuterol and Ipratropium therapy four times daily in relieving dyspnea among patients with ECOPD presenting to the ED and requiring …
Phase: PHASE4 • Sponsor: University of Tennessee Graduate School of Medicine • Aim: Disease control
Last updated Jul 25, 2026 00:00 UTC
-
Can a smart drug deliver a toxic payload directly to cancer cells?
Disease control Not yet recruitingThe goal of this clinical trial is to learn if ADC drug MC002 works to treat locally advanced/metastatic solid tumors in adults. It will also learn about the safety of MC002. The main questions it aims to answer are: Does participants tolerate the drug MC002 ? What medical probl…
Phase: PHASE1 • Sponsor: Hangzhou MacroLink Biopharmaceutical LLC • Aim: Disease control
Last updated Jul 26, 2026 00:00 UTC